Navigation Links
Onyx Pharmaceuticals Announces Management Changes
Date:10/4/2007

cializing and developing Nexavar(R), a small molecule drug, with Bayer HealthCare Pharmaceuticals Inc. Nexavar has been approved for the treatment of advanced kidney cancer. For more information about Onyx's pipeline and activities, visit the company's website at: http://www.onyx-pharm.com.

Nexavar(R) (sorafenib) tablets is a registered trademark of Bayer HealthCare Pharmaceuticals Inc.

This news release contains "forward-looking statements" within the meaning of the federal securities laws. These forward-looking statements include, without limitation, statements regarding the planned commercial launch of Nexavar as a treatment for liver cancer and the anticipated contributions of Onyx's management team. These statements are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated. These risks and uncertainties include, without limitation, the risks (i) that Nexavar may never be approved for use in liver cancer or that its approval may be significantly delayed, and (ii) that we depend upon our collaborative relationship with Bayer to manufacture and to further develop and commercialize Nexavar. These and other risk factors are discussed under "Risk Factors" in Onyx's Annual Report on Form 10-K for the year ended December 31, 2006, as well as Onyx's subsequent quarterly reports on Form 10-Q, filed with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release. Onyx undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.


'/>"/>
SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Supply of Radiopharmaceuticals Hampered by Attacks
2. FDA approves Watson Pharmaceuticals Oxytrol patch
3. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
4. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
5. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
6. Top Pharmaceuticals Influence Doctors Prescriptions
7. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
8. Personalized Medicine and Innovative Pharmaceuticals
9. New lease of life for asthmatics by Accentia Biopharmaceuticals
10. Pravastatin Launched by Watson Pharmaceuticals
11. Tata Industries picks up stake in Indigene Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... July 25, 2014 Stwd.co.uk, one of ... new collection of cheap evening dress for ... launch a big promotion for these items. They are ... promotion will last until August 30. , “We are ... Beside evening outfits, we have a large number of ...
(Date:7/25/2014)... Healthpointe is proud to announce that ... Occupational Medicine services to the community. The La ... workers’ compensation cases. , The Occupational Medicine ... care treatment management, return-to-work and wellness programs, on-site ... physicals, and illness and injury treatments. , ...
(Date:7/25/2014)... MEDICC announced diplomas went to 1,382 new MDs ... of Havana’s graduation ceremonies that also included graduates of ... 879 international graduates from 28 countries, 20 were ... and hundreds of parents packed the Cuban labor union ... President Ramón Machado Ventura and Minister of Health Roberto ...
(Date:7/25/2014)... Washington, DC (PRWEB) July 25, 2014 ... against some health plans for providing inadequate access to ... serious threats to the health and safety of beneficiaries ... of drug coverage determinations, and CMS is taking quick ... 5, the Atlantic Information Services webinar, “Avoiding Costly ...
(Date:7/25/2014)... Wa (PRWEB) July 25, 2014 ... Pdf review recently updated by Vkool.com, this ... people how to treat some common types ... hemorrhoids and internal hemorrhoids ,     Young ... pregnancy with hemorrhoids ,     Very large ...
Breaking Medicine News(10 mins):Health News:Famous Supplier Stwd.co.uk Announces Its New Selection of Evening Dresses for Women 2Health News:Healthpointe Offering Occupational Medicine Services in La Mirada 2Health News:MEDICC Congratulates 20 New MDs for the USA Graduating from Cuba’s Latin American Medical School 2Health News:MEDICC Congratulates 20 New MDs for the USA Graduating from Cuba’s Latin American Medical School 3Health News:Aug. 5 Webinar to Offer Strategies for Preventing Rx Access Issues and Avoiding Part D Sanctions 2Health News:Hemorrhoid No More Pdf Review Exposes Jessica Wright's Guide For Treating Hemorrhoids – Vkool.com 2Health News:Hemorrhoid No More Pdf Review Exposes Jessica Wright's Guide For Treating Hemorrhoids – Vkool.com 3
... be associated with increased risks of major neck artery tears ... of Neurology, the scientific journal of the American Academy of ... large blood vessels,” said the study’s senior author Wengui Yu, ... and a member of the American Academy of Neurology. ...
... Previous studies on rats prove experiencing control over stressful ... face without developing depression like syndrome. ,Scientists ... the workings of the brain circuitry that inoculates against ... ,Control not only activated the brain's executive hub, ...
... the evaluations published in PLoS Medicine, an innovative social ... strips to encourage gay and bisexual men in San ... an increase in syphilis tests. ,The cartoons ... posted on the streets, on bus shelters, on gay ...
... PLoS Medicine shows that Health Care Workers (HCWs) in developing ... found //to have latent infection with tuberculosis, which is active. ... patients and others. ,One third of the ... causes TB. In most people, the bug causes no health ...
... by researchers that help those who have it, to live ... effect upon the mental faculties also. This new research work ... Medicine of Yeshiva University. December 26, 2006 issue of Neurology ... is the director of the Institute for Aging Research at ...
... hand of a little boy, looking at a row of ... was in wreck two years ago, washed away by the ... now. Along the innocent-looking silver beaches about 80 km south ... men are back to weaving nets. ,'Udavum ...
Cached Medicine News:Health News:Prior Experience to Stress Acts as an Immunization 2Health News:You may Live Long and Think Clear With a Variant Gene 2Health News:Tsunami-Hit Coastal Regions Needs More Relief 2
(Date:7/25/2014)... BERWYN, Pa. , July 25, 2014  AMETEK, ... appointment of Kurtis L. Goos as Vice ... Engineered Materials, Interconnects and Packaging (EMIP) Division. ... has extensive general management and business development experience, especially ... to make important contributions to the continued growth and ...
(Date:7/25/2014)... July 25, 2014 /PRNewswire-iReach/ -- Dr. Michael Gabriel ... Pediatrics, reacts to a recent study, which shows how grief ... - http://photos.prnewswire.com/prnh/20140723/129709 According to ... stress are more likely than others to grow up overweight ... There were two specific types of stress that ...
(Date:7/24/2014)... , Deutschland, und MARSEILLE ... -- , Weltweite ... ermöglicht QIAGEN die Entwicklung von Tests ... für Blutkrebs  Neuer Test weist ... mit Knochenmarkserkrankungen (myelodysplastischen Syndromen) einen günstigen Krankheitsverlauf ...
Breaking Medicine Technology:AMETEK Names Kurtis L. Goos, Vice President & General Manager, Engineered Medical Components 2Dr. Michael Gabriel of GPM Pediatrics, a Noted Staten Island Pediatrics Clinic, Comments on Study, Which Names Grief as a Cause of Obesity in Children 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5
... XTENT, Inc.,(Nasdaq: XTNT ) today announced a ... Notified Body for CE Mark approval of its ... that recently,presented six-month follow up results from the ... Agency, which reviews the drug formulation,submission of XTENT,s ...
... Make Qnexa the New Clinical Gold, Standard Drug ... Resources, WALTHAM, Mass., June 12 Decision Resources, ... on pharmaceutical and,healthcare issues, finds that a drug that ... would earn a 40 percent patient share in,the obesity ...
Cached Medicine Technology:XTENT Announces European Regulatory Update 2XTENT Announces European Regulatory Update 3A Drug With Efficacy Superior to That of Xenical at Inducing Weight Loss Would Earn a 40 Percent Patient Share in the Obesity Drug Market 2
... System is a rapid, real-time thermal cycler ... samples. By automating much of the testing ... programmable, it is the fastest, easiest to ... the market. The SmartCycler delivers highly accurate ...
... is the newest real-time PCR instrument offered ... offers six detection channels that provide fluorescence ... and 710nm. Perform rapid PCR due to ... with glass capillaries. Virtually any published protocol ...
Mx3000P instrument, desktop computer, Mx3000P software package, user's manual, one Brilliant QPCR Reagent of your choice, and custom filter wheel with 4 filters chosen from: FAM/SYBR Green I, TET, HE...
... standard in QPCR with the Mx4000 multiplex ... superior performance, more flexibility, and reasonable pricing. ... with Windows 98SE and Pentium III (or ... Speakers, Surge Protector (US only), Mx4000 Software ...
Medicine Products: